Safety Shot Announces Strategic Partnership with Chip Quigley and Ari Freedman
The Executives
Quigley brings over two decades of experience in the
Freedman has successfully led countless brands to achieve significant growth and market penetration through development and distribution, and brings to the table a keen eye for market trends and consumer behavior. His expertise will play a crucial part in expanding Safety Shot's distribution channels and ensuring that the product reaches a wider audience.
"We are thrilled to partner with Chip and Ari to tap their expertise to further elevate Safety Shot's market presence through high-profile events and marketing campaigns as well as a strategic oversight on distribution," said
This announcement comes on the heels of Safety Shot's Northeast expansion plan and partnership with Mr. Checkout and Capital Drugs pharmacies across
For more information, visit www.drinksafetyshot.com.
About Safety Shot, Inc
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
View original content to download multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-strategic-partnership-with-chip-quigley-and-ari-freedman-302181122.html
SOURCE Safety Shot
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amber Premium Transforms into AMBR, Dedicated to Building Specialized AI Agents for Finance, Enterprise, and Growth
- Advanced Procurement for Universities & Colleges (APUC) Enhances Student Mental Health Support Across Scotland
- Resolution Therapeutics partners with the Blood Centers of America, Inc. to support broad patient access to its experimental Regenerative Macrophage Therapy in the U.S.
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share